Centene (CNC) Raises 2024 Guidance by $2.5 Billion, Signaling Strong Growth Outlook
Centene Corporation reports a successful Q4, with a revenue of $39.46 billion and an EPS of $0.45.
Editorial disclosureRead more
All reviews, research, news and assessments of any kind on The Tokenist are compiled using a strict editorial review process by our editorial team. Neither our writers nor our editors receive direct compensation of any kind to publish information on tokenist.com. Our company, Tokenist Media LLC, is community supported and may receive a small commission when you purchase products or services through links on our website. Click here for a full list of our partners and an in-depth explanation on how we get paid.
Centene Corporation (NYSE: CNC), a Fortune 500 company and leader in healthcare services, has recently announced its financial results for the fourth quarter and the full year of 2023, marking significant achievements and setting a confident tone for 2024.
Centene Corporation Reports $39.46B in Revenue for Q4
In the last quarter of 2023, Centene Corporation reported robust revenues of $39.46 billion, with premium and service revenues at $35.34 billion. The health benefits ratio, a key measure of the company’s medical costs as a percentage of premium revenues, was recorded at 89.5%.
The selling, general, and administrative (SG&A) expense ratio, another critical metric indicating the efficiency of operations, was slightly higher at 9.9% on a GAAP basis and adjusted to 9.7%. Despite these figures, the adjusted diluted EPS for Q4 came in at $0.45, showcasing the company’s ability to manage costs and optimize operations effectively.
CNC Outperforms Expectations in Q4
When juxtaposed with market expectations, Centene’s performance in the latest quarter presents a mixed picture. The company’s earnings per share (EPS) of $0.45 slightly outperformed the anticipated $0.42, underscoring a prudent management approach and operational efficiency. However, the reported revenue of $39.46 billion also surpassed the expected $36.18 billion, highlighting Centene’s ability to generate higher revenue streams and maintain a strong competitive stance in the healthcare sector.
CNC Increases 2024 Guidance by $2.5 Billion
Looking ahead, Centene is optimistic about its future trajectory. The company has increased its 2024 premium and service revenues guidance by $2.5 billion, reflecting confidence in its growth strategy and market opportunities. The reiterated floor for 2024 adjusted diluted EPS of more than $6.70 signifies Centene’s belief in its operational strength and the effectiveness of its strategic initiatives. These forward-looking statements suggest a focus on expanding core businesses, leveraging strategic partnerships, and continuing to drive cost-efficiency across operations.
Disclaimer: The author does not hold or have a position in any securities discussed in the article.
Tim Fries
Tim Fries is the cofounder of The Tokenist. He has a B. Sc. in Mechanical Engineering from the University of Michigan, and an MBA from the University of Chicago Booth School of Business. Tim served as a Senior Associate on the investment team at RW Baird's US Private Equity division, and is also the co-founder of Protective Technologies Capital, an investment firm specializing in sensing, protection and control solutions.
